v3.26.1
Revenue (Tables)
 12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregated Revenue by Product and Services

The following table provides information about disaggregated revenue by product and services:

 

       
   Year Ended December 31, 
   2025   2024 
Product sales, net  $13,175   $35,336 
Services   5,432    5,140 
License, royalty and other   7,943    13,744 
Total revenues  $26,550   $54,220 
Schedule of Changes in Deferred Revenue from Contract Liabilities

The following table provides changes in deferred revenue from contract liabilities:

 

Schedule of Changes in Deferred Revenue from Contract Liabilities

   2025   2024 
Balance at January 1  $6,255   $6,020 
Deferral of revenue (1)(3)   8,193    5,731 
Recognition of unearned revenue (2)   (6,394)   (5,496)
Balance at December 31  $8,054   $6,255 

 

  (1) Deferral of revenue includes $2,492 in 2025 resulting from payments received in advance of performance under the biobanking services storage contracts that are recognized as revenue under the contract as performance is completed.
     
  (2) Recognition of unearned revenue for the year ended December 31, 2025 includes $3,492 that was included in the beginning deferred revenue balance at January 1, 2025.
     
  (3) Deferral of revenue includes $2,890 in 2025 resulting from product purchase credits issued to Defeye as consideration for Defeye’s Series Seed – 2 Preferred Stock (Note 22).